Skip to main content

Table 2 Frequently used human NB cells lines for preclinical testing

From: Developing preclinical models of neuroblastoma: driving therapeutic testing

Cell Line

MYCN Status

ALK Mutation

P53 mutation

Preclinical Testing References

KELLY

Amplified

WT

WT

[69,70,71,72,73,74,75]

CHP-212

Amplified

WT

WT

[76, 77]

SKNAS

Non-Amplified

WT

H168R

[76, 78,79,80,81,82,83,84,85,86]

SH-SY-5Y

Non-Amplified

F1174 L

WT

[70, 71, 75, 78, 87,88,89]

IMR-32

Amplified

WT

WT

[80, 88, 90, 91]

IMR-05

Amplified

WT

WT

[37, 86, 89, 92]

LA-N-5

Amplified

R1275Q

WT

[71, 93, 94]

NB-1

Amplified

WT; Amplified

WT

[95, 96]

SK-N-BE(2)

Amplified

WT

C135F

[75, 78, 83, 89, 86, 97]

SK-N-BE(2)-C

Amplified

WT

C135F

[78]

CHP-134

Amplified

WT

WT

[78, 89, 98, 99]

SK-N-DZ

Amplified

WT

R110L

[82, 84, 85]

NB-1691

Amplified

WT

WT

[83, 100, 101]